ABSTRACT
INTRODUCTION
Photodynamic therapy (PDT) is a relative new treatment used for different types of the tumors (Dougherty, 1993 , Sibata et al., 2000 , in which a photosensitizing agent is injected into the patient bloodstream or topically applied to the patient skin promoting drug accumulation preferentially in the tumor. After 24 to 72 h, the tumor is exposed to a visible laser light (wavelength around 630 nm). The photosensitizing molecules absorb the light and produces free radicals and singlet oxygen that destroy the cancer cells. Photosensitizers have a stable electronic configuration corresponding to a singlet state in their ground-state energy level. Following the absorption of a visible light photon, the molecule is promoted to an excited state, which is also a singlet state and is short-lived. The photosensitizer returns to the ground state by emitting a photon or by internal conversion with energy loss as heat. It is also possible that the molecule may convert to the triplet state via an intersystem crossing, which involves a change in the spin of an electron. This alternative is the one relevant to PDT. There are basically two mechanisms, Type I and Type II reactions, by which the triplet state photosensitizer can react with the biomolecules promoting cellular damage (Oleinick and Evans, 1998) . Type I reaction involves the transfer of the electron, or hydrogen atoms producing radical forms of the photosensitizer, or the substrate (Oleinick and Evans, 1998; Fritsch and Ruzicka, 2003) . These radicals then react rapidly, usually with oxygen, resulting in the production of highly reactive oxygen species, such as superoxide (Oleinick and Evans, 1998) , the peroxide anions ( − 2 2 O ) (Oleinick and Evans, 1998; Haylett et al., 2003) , hydroxyl radicals ( OH -) (Haylett et al., 2003; Schaffer et al., 2005) (Haylett et al., 2003) . Type II reactions produce the electronically excited and highly reactive state of oxygen known as singlet oxygen ( 2 1 O 0 ) (Wilson, 2002) . Direct interaction of the excited triplet state photosensitizer with the molecular oxygen (which, unusually, has a triplet ground state) results in the photosensitizer returning to its singlet ground state and the formation of singlet oxygen, which acts as the cytotoxic agent. The relative weight of each type mechanism is still under debate. Besides being an exciting new technique for the cancer treatment, the PDT has opened up new possibilities to enhance the conventional radiotherapy due to its synergistic ionizing radiation effects when the target tissue is photosensitized with the hematoporphyrin normally employed in the PDT (Schaffer et al, 2002a) , The effect on the normal skin of this combined modality of the treatment has been reported as producing significant increase of skin necrosis ( Benstead and Moore, 1990) . The modification of radiosensitivity by porphyrins derivatives in several in vivo and in vitro experiments have also been studied (Schaffer et al., 2001; Schaffer et al., 2003; Schaffer et al., 2005; Moan and Petersen, 1981; Bellnier and Dougherty 1986; Zhao et al., 1986; Zhang et al., 1996; Kostron et al., 1986; Chen, 1985; Colasanti et al., 2004; Lukšien÷, 2004) . The mechanism of this radiosensitizing effect is not completely understood (Schaffer et al., 2005) . In vitro data, however, support the hypothesis that the radiosensitizing action involves OH-radicals (Jori, 1996) in addition to a potential impairment of repair mechanisms after sub lethal damage of ionizing radiation (Schaffer et al., 2005) . To our knowledge, little has been published in the enhancement of the radiation effect due to the presence of photosensitizer for in vitro studies using chemical procedures. The Fricke dosimeter (Klassen et al., 1999) 
MATERIALS AND METHODS

Irradiation Setup
An X-ray beam from a Pantak x-ray tube set at 70 kV with a 1.03-mm aluminium filter was used to irradiate all the samples in the present work. The energy was verified with a Eurisys (Hewlett Packard) Ge spectrometer. The X-ray beam halfvalue layer was measured to be 3.1 mm of aluminium. The ionization chamber and the Fricke dosimeter (with and without the photosensitizer) were set at a distance of 500 mm, at the central axis of the X-rays beam which was defined as 75 x 75 mm at the calibration distance.
Absorbed Dose determination
The mean value of a set of five measurements made with a PTW type 2232 plane-parallel ionisation chamber inserted in a Plexiglas phantom (110 mm long, 110 mm wide and 80 mm deep) was used to calculate the absorbed dose to water. Another Plexiglas phantom with the same physical dimensions, appropriate to fit the vacutainers, was used to irradiate the vials with the Fricke dosimeter and Photogem ® doped Fricke solutions. The doses delivered to the Fricke solution and the Photogem ® doped Fricke solutions were based on the readings of a transmission ionisation chambers connected to a Farmer NE type 2670 electrometer.
Standard and the Photogem ® doped-Fricke solutions
The Fricke solution was prepared with 0.392 g of (NH 4 ) 2 Fe(SO 4 ) 2 .6H 2 O, 0.060 g of NaCl, 22 ml of H 2 SO 4 and made up to 1,000 ml with Milli-Q water (18.2 MΩ.cm). The reference Photogem ® doped Fricke solution was prepared by adding 0.0015 g of Photogem ® to 1,000 ml of Fricke solution. This solution was diluted to prepare solutions with concentrations of 2, 4 and 6 mg/l. A volume of 3 ml of Fricke solution and Photogem ® doped Fricke solutions were transferred to a 10 ml sterile vacutainer using a needle coupled to a polypropylene tube. The irradiated solutions were transferred directly from the vacutainer to a 10 mm length curvette and the optical densities were measured in the range of 220 to 340 nm using a Beckman Counter Model DU 640 spectrophotometer. As a first approximation, the doses obtained with the Fricke solution were calculated according to equations 1, 2 and 3 (Olszanski et al., 2002; IAEA, 1977; Klassen et al., 1999) 
Where ε is the molar extinction coefficient of Fe 3+ at 25 o C (218.7 m 2 mol -1 ) (Attix, 1986) , N A is the Avogadro's number, d is the optical pathway (10 mm), ρ is the solution density (1,022.7 kg.m -3 ) (Olszanski et al., 2002) . The factors f 1 and f 2 were used to correct the OD dependence with the temperatures, T i (°C), of the solution during the irradiation, and T R (°C) during the measurement . The value for the chemical yield, the G(Fe , was taken from ICRU Report 17 for dosimetry of X-Rays Generated at Potentials of 5 to 150 kV (ICRU, 1970) . The change in the irradiated solution's optical density, ∆OD, relative to the non-irradiated solution at a wavelength of 304 nm (absorption peak of Fe 3+ ), of the Fricke solution was calculated by subtraction of the average optical density of the control (non irradiated Fricke solution). The change in the optical density (304 nm) of the doped-Fricke solution was obtained by subtraction of the average optical density of the non irradiated doped-Fricke solution.
Long and short term consistency and reproducibility
The long and short term consistency and reproducibility of the Photogem ® doped Fricke solution was evaluated by irradiating 500 ml solution with approximately 40 Gy. The solution was stored at room temperature (25) (26) (27) (28) (29) o C), and the optical densities measurements were made during a period of 480 h. Fig. 1 shows the spectrum of the irradiated Photogem ® doped Fricke solution (PDFS). These spectra were obtained from the Fricke solution doped with 2.5 mg/l of Photogem ® and irradiated with doses of 5, 7.5, 10, 12.5 and 15 Gy. The spectra of the PDFS were quite similar as those observed for the conventional Fricke dosimeter. The maximum optical densities values occured around 224 and 304 nm, indicating that the maximum peaks absorption were due to the presence of ferric ions (Fe 3+ ) in the solution. Fig. 2 shows the short and long term consistency and reproducibility of a Fricke solution doped with 2.5 mg/l Photogem ® irradiated with 40 Gy. Results showed an oxidative process in order of 0.013%/h, which resulted in an increase in the response of the doped Fricke solution of 7%. Comparable with the conventional stability of the Fricke dosimeter, this value was considerably higher, since the long term stability of the Fricke dosimeter, irradiated with the same X-ray beam quality, was in order of ± 1.8% during a period of about 600 h. This meant that the presence of the photosensitizer affected the reproducibility of the Fricke dosimeter. Assuming that the Fricke solution was tissue equivalent, the concentrations of Photogem ® in the Fricke solutions used in this work was close to that usually applied in a patient undergoing the PDT therapy (1.5 mg Photogem per kg patient weight (Bagnato et al, 2002) . The experiments made with intravenous administration and the distribution of the photosensitizer porfimer sodium, Photofrin ® , through the body in clinical studies of cancer patients have shown that the mean serum concentration was of the order of 3.5 mg/l for an injection based on 2.0 mg/kg (Bellnier and Dougherty, 1996) . Such concentration was not far from those used in this work so that, by the reasons described above, a concentration of 4 mg/l could be used for the Photogem ® doped Fricke solution in the experiments involving ionization radiation.
RESULTS AND DISCUSSION
General overview
The linear relationship between the optical densities and these concentrations irradiated with 15 Gy is shown in Fig. 4 (Klassen et al., 1999) .
The yield of Fe 3+ produced on the radiolysis of the aerated acidified Fe 2+ solution gives a measure of the total yield of the reactive reducing and oxidizing species escaping the radiation track into the bulk. The kinetics and the yield of Fe 2+ are determined by the reactions as below (Harris and Pimblott, 2002) , from the biological point of view. The hydroxyl free radical is the primary oxidizing species and can be used to oxidize and break apart the organic molecules. The hydrogen peroxide can also break apart the organic molecules through the Fenton's reaction (Satoka, 2001) . Equation 8 can be broken down into a hydroxide ion and a hydroxyl free radical. Hydroxyl radical has a predominant role of the in ionizing radiation damage and minor involvement in PDT damage (Henderson and Miller, 1986) , as well as in the yield of Fe 3+ in the Fricke dosimeter (Eq. 4). When ionizing radiation interacts with a medium doped with a photosensitizer, such as, Photofrin ® , it has been proposed ) that its radiosensitivity is connect with the oligomers that can efficiently interacted (Jori, 1996) with some cytotoxic transient intermediates such as hydroxyl radicals, which are known to be generated as a result of the primary interaction of the X-ray with the water. In this connection, the Photofrin ® acts as a radiation amplification factor, by minimizing the possible onset of the repair processes, which often limit the radio-induced cell damage . This mechanism of action has been confirmed in the case of another porphyrin, namely, gadolinium texaphyrin, which is used as a radiosensitizer (Viala et al., 1999; Rowinsky, 1999) . When light impinges in a Fricke solution doped with the Photogem ® , there is an enhancement in the response of the dosimeter (Austerlitz et. al., 2006) . In this case, such enhancement is assumed to be due to the production of free radicals caused by the Type I reaction. When ionizing radiation strikes the Fricke solution doped with the Photogem ® , as proposed by , there is a radiation amplification factor (here assumed to be amplification of free radials) associated with the production of the light, including Bharat energies that can excite the electrons (Padmanabha-Rao, 2001 ), a kind of Type III reaction, which enhances the Fricke dosimeter response.
Interaction of light and ionizing radiation with tissue and with Fricke solution doped with Photogem
Tumor growth inhibition and Fricke dosimeter enhancement
The effects of the hematoporphyrin derivative, light, and 60 Co irradiation in a rat glioma model, using an in vivo and an in vitro clonogenic assay, have been reported by Kostron (1986) . It was fond that 60 Co irradiation in the presence of an hematoporphyrin derivative produced a significant tumor growth inhibition (up to about 50%) and this growth inhibition was directly related to the concentration of the hematoporphyrin derivative. This result corroborated with observations in a recent publication by Schaffer et al. (2002b) where Photofrin® II (an hematoporphyrin derivative produced by the AXCAN INC -Canada and equivalent to Photogem ® ) was used as a specific radiosensitising agent in the patients with the bladder cancer (Sokolov, 1995) . They observed that in similar conditions, the patient injected with 1 mg/kg had a noticeable increase on the radiotherapy response. They claimed a 40% reduction of the tumors after the radiotherapy due to the presence of the porphyrin. Also, experimental work using animals have shown that the time for tumor to recover to the original size after a certain dose of the radiation is increased by almost a factor of two when the Photofrin® II is used as an enhancement agent for the radiotherapy (Schaffer et al., 2001) . Henderson (1986) reported the involvement of free radical species in the process of cell killing by comparing the effect on cell survival following photodynamic therapy and gamma irradiation. Apparently 90% of the radiotoxic effects could be due to the indirect effects of radiation (Walicka, 2000) . In this work pronounced enhancement of the Photogem ® doped Fricke solution response and its direct relationship with the concentration of the hematoporphyrin derivative was found. This suggested that a Fricke solution doped with photosensitizer under X-rays irradiation not only detected the free radicals produced by the water hydrolysis, but also those from the Type I reaction. Therefore, such a dosimeter could be used to evaluate the amount of the free radicals produced by a particular photosensitizer and its correlation with the indirect mechanisms of radiation in phototherapy combined with the radiotherapy. The Fricke solution could also be used in the determination of the concentration of the Photogem ® in conventional PDT application. The combination of the light together with the ionization radiation could eventually reveal the level of the light dose necessary to promote the desired level of the free radical formation that can be used in the development of a PDT dosimeter as well as the possible degradation of a photosensitizer with the ionizing radiation, which can be done by irradiating the solution with light and ionizing radiation and vice versa. This is a subject that still demands a considerable investigation and it is under investigation by our group. No further study was done concerning the overall uncertainty in the determination of absorbed dose. However, the reproducibility of the Fricke dosimeter did not exceed ± 2.5% (Souza and Austerlitz, 2005) and the accuracy in the absorbed dose determination with ionization chambers was in the order of ± 3.5%. The precision in the measurements done with the Photogem ® doped Fricke solution measurements was ± 3.5% (1 sd).
CONCLUSIONS
From the results, the following conclusions could be drawn:
• Under the irradiation with the ionizing radiation, there was an enhancement in the response of the Fricke solution doped with the Photogem ® which was proportional to the concentration of the photosensitizer; • as the mechanism behind the Fricke dosimetry was the formation of the free radicals, the enhancement of the response of the Photogem ® doped Fricke solution was attributed to the Type I reaction, and • Fricke solution doped with the photosensitizer could also be used to compare the production of some free radicals from different radiosensitizers under the irradiation with ionizing radiation. 
RESUMO
